Gefarnate
Gefarnate
Gefarnate (pronounced: /ɡɛˈfɑːrneɪt/) is a drug used in the treatment of gastric ulcer and gastric mucosal lesions. It is known for its ability to stimulate the production of mucus in the stomach, providing a protective barrier against gastric acid.
Etymology
The term "Gefarnate" is derived from the chemical name of the drug, which is "2,3-dihydroxypropyl octadecanoate". The name is a combination of the Greek words "ge" (earth), "farn" (a type of plant), and "ate" (a suffix used in chemistry to denote a salt or ester of an acid).
Usage
Gefarnate is used in the treatment of gastric ulcers and gastric mucosal lesions. It works by stimulating the production of mucus in the stomach, which forms a protective barrier against the damaging effects of gastric acid. This helps to promote healing of the ulcer or lesion and reduces the risk of further damage.
Related Terms
- Gastric ulcer: A type of peptic ulcer that develops in the lining of the stomach.
- Gastric mucosal lesion: Damage to the lining of the stomach, which can be caused by a variety of factors including stress, certain medications, and bacterial infection.
- Mucus: A slippery substance produced by the mucous membranes and glands, which provides protection and lubrication in many parts of the body.
- Gastric acid: A digestive fluid formed in the stomach, which is responsible for breaking down food and killing bacteria.
External links
- Medical encyclopedia article on Gefarnate
- Wikipedia's article - Gefarnate
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski